SORTING OF LIPID-PROTEIN COMPLEX IN EPITHELIAL CELLS
Project Number5R01GM047897-07
Contact PI/Project LeaderBROWN, DEBORAH ANN
Awardee OrganizationSTATE UNIVERSITY NEW YORK STONY BROOK
Description
Abstract Text
Detergent-resistant membranes (DRMs) isolated from mammalian cells have
been implicated in a diverse set of functions, ranging from intracellular
sorting in polarized epithelial cells, to cell-surface signal transduction,
to the structure of non-clathrin-coated plasma membrane pits called
caveolae. Each of these roles will be examined, and a model explaining he
structure of these membranes will be tested. Cholesterol-rich model
membranes contain distinct domains; a novel phase called the liquid-ordered
phase (Io) phase in addition to the liquid-crystalline (Ic) phase. Io
phase lipids are packed more tightly than those in the Ic phase, but have
more mobility than gel phase lipids. DRMs isolated from cells appear to be
present in a phase similar to the Io phase. The long-term goal of this
work is to determine how these domains function in cells. Many proteins
that can be isolated from cells in DRMs are modified with saturated acyl
chains (myristate and/or palmitate), that fit well into ordered domains.
Three such proteins will be purified and incorporated into model membranes
that contain Io phase domains; the caveolar coat protein caveolin, the Src-
family kinase Yes, and the G protein Gi. The ability of these proteins to
associate with DRMs from these liposomes in the absence of other proteins
will be determined, as will the dependence of this behavior on protein
acylation. Possible effects of Io phase domains on the function of these
proteins will also be explored. These studies could have important health-
related implications, as signaling proteins such as Src-family kinases can
be oncogenic. Previous studies suggest that DRMs can be isolated from
intracellular membranes as well as plasma membranes. DRMs will be isolated
from the Golgi apparatus. Proteins found to be enriched in Golgi-derived
DRMs may be important in sorting and trafficking along the secretory
pathway, and will be further characterized. Complementary studies using
cells and motel membranes will test our model that DRMs exist in cells as
discrete domains. Recent results suggest that lipids with high acyl chain
melting temperatures, such as sphingolipids, promote the formation of the
Io phase in the presence of cholesterol. The lipid composition of DRMs
from cells depleted of sphingolipid and/or cholesterol, and of model
membranes that form DRMs, will be examined to test the correlation between
formation of an Io-like phase and detergent-insolubility. Additional
methods for examining the Io-like phase in model membranes and possibly in
cell membranes will be used. Finally, the ability of the sphingolipid-poor
inner leaflet of the plasma membrane to form DRMs will be tested using
inside-out erythrocyte ghosts.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
G proteinGolgi apparatusSDS polyacrylamide gel electrophoresisapical membranebiological signal transductioncaveolinscell membraneelectron microscopyelectron spin resonance spectroscopyepitheliumgel electrophoresisglycosphingolipidsimmunoprecipitationintracellular transportlaboratory mouselaboratory ratlipid structurelipid transportmembrane lipidsmembrane proteinsphosphatidylinositolsprotein kinaseprotein purificationprotein structure functionprotein transporttissue /cell culture
No Sub Projects information available for 5R01GM047897-07
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01GM047897-07
Patents
No Patents information available for 5R01GM047897-07
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01GM047897-07
Clinical Studies
No Clinical Studies information available for 5R01GM047897-07
News and More
Related News Releases
No news release information available for 5R01GM047897-07
History
No Historical information available for 5R01GM047897-07
Similar Projects
No Similar Projects information available for 5R01GM047897-07